Redox biochemistry of mammalian metallothioneins
Tirzepatide is administered subcutaneously once weekly, with peak plasma concentration occurring 2472 hours post-injection
John GB, Gallardo TD, Shirley LJ, Castrillon DH
The practical result is accelerated healing from both acute injuries and chronic repetitive stress
56 weeks max with breaks Injection Site: Subcutaneous preferred for consistent delivery Goal Phases: Recomp, injury recovery, performance support Example Cycle (4 Weeks): Weeks 14: 15 mcg IGF-1 LR3 post-workout, 5x/week Paired with: Swolverine ZMT for hormone and sleep support, Collagen, and clean carb/protein intake Stack potential: MK-677 (low dose), or run as a solo peptide for clean recovery Both men and women should avoid exceeding 8 weeks of continuous IGF-1 LR3 use without taking a break, as prolonged elevation may increase insulin desensitization or desensitize receptors